Daily State of the Markets 
Wednesday Morning – October 20, 2010  

In case you haven’t noticed, I find that there is usually a well worn Wall Street cliché available to fit just about every situation. But the trouble this morning is I’m having difficulty deciding which saying is more appropriate. On the one hand, the old saw “one day does not a trend make” would seem to fit the market’s first crummy day in two months. But on the other hand, one of my all-time favorite Wall Streetisms reminds me that on the street of dreams, “Once is a trend, twice is a tradition, and three times is a commandment!”

So, should we assume that the market has changed its tune and is now going to head lower for a while? Or is it better to stay with the prevailing trend that, up until yesterday, had produced an intraday advance of nearly +14% in under two months? While predicting the future isn’t my strong suit, we’re of the mind that we don’t have enough evidence to make a decision at this point in time. And although this may sound like a copout, did you really expect me to expose my noggin to Ms. Market’s baseball bat with a prediction?

However, I can say that we may be seeing the beginning of what could wind up being a character change for the stock market. You see, up until the moment that IBM and Apple reported earnings, all news was good news. Remember, with the Fed about to start buying up bonds again, we had a head-stocks-win, tails-stocks-win-too environment. It didn’t matter whether economic data was good or bad, it was good for stocks. And earnings, while they are always nice, weren’t necessarily a prerequisite for a rally because all eyes were fixed squarely on Mr. Bernanke’s band of bond buyers.

But that attitude of gratitude seemed to change after Big Blue and the King of Cool let their numbers fly Monday night. While both tech bellwethers reported strong numbers on just about every front, traders found something to get uptight about and took the stocks lower post haste. Thus, I will submit that the action in these two companies suggests that those engaged in the “buy the rumor, sell the news” trade of the day might be getting an itchy trigger finger.

So, when China surprised everyone by raising interest rates for the first time in nearly three years, it wasn’t shocking to see the glass-is-overflowing gang head for the exits – and in a hurry yesterday morning. Thus, in the early going at least, it looked like the bears had taken possession of the ball and were looking to score.

But up until the time Bloomberg reran a headline regarding Bank of America being asked to buy back a cool $47 billion in mortgages, the bulls were hanging tough. And right up until the time everyone started digging into the BAC story, it looked like it was anybody’s ball game. But, as one might suspect, allegations of misdoings in the mortgage service business and the anticipated penalties put the kibosh on any upside inklings the bulls might have had.

Although I can’t make a prediction about the near-term direction of the market, I can say that if this thing with Bank of America gains traction with the media and investors alike, our furry friends just might start singing a happy tune.

Turning to this morning… Stocks are attempting to rebound a bit after yesterday’s selling. Surprisingly, the declines in Asia were modest and European bourses are actually higher at the moment.

On the economic front… We don’t have any economic data to review before the bell but we will get the Beige Book at 2:00 pm eastern and then China’s Industrial Production, CPI, PPI, and Retail Sales this evening at 10:00 pm.

Finally, consider embracing an “attitude of gratitude” during the day today…

Pre-Game Indicators

Here are the important indicators we review each morning before the opening bell…

  • Major Foreign Markets:
    • Australia: -0.69%
    • Shanghai: +0.07%
    • Hong Kong: -0.87%
    • Japan: -1.65%
    • France: +0.46%
    • Germany: +0.29%
    • London: +0.16%

     

  • Crude Oil Futures: + $0.73 to $80.22
  • Gold: + $5.50 to $1341.50
  • Dollar: higher against the Yen, lower vs. Euro and Pound
  • 10-Year Bond Yield: Currently trading at 2.491%

     

  • Stocks Futures Ahead of Open in U.S. (relative to fair value): 
    • S&P 500: +4.90
    • Dow Jones Industrial Average: +39
    • NASDAQ Composite: +9.27  
Yesterday’s Earnings After the Bell

Company

Symbol

EPS
Reuters
Estimate
Boston Scientific BSX $0.00 $0.06
Gilead Sciences GILD $0.90 $0.87
Intuitive Surgical ISRG $2.14 $2.12
Juniper Networks JNPR $0.32 $0.31
SLM Corp SLM $0.35 $0.27
Stryker SYK $0.62 $0.77
Western Digital WDC $0.84 $0.81
Yahoo! YHOO $0.16 $0.15

Earnings Before The Bell

Company

Symbol

EPS
Reuters
Estimate
Abbott Labs ABT $1.05 $1.04
Amphenol APH $0.73 $0.68
Boeing BA $1.12 $1.03
Check Point Software CHKP $0.63 $0.59
Comerica CMA $0.33 $0.41
Quest Diagnostics DGX $1.05 $1.00
Eaton ETN $1.60 $1.37
Hudson City Bancorp HCBK $0.25 $0.26
Marshall & Ilsley MI -$0.32 -$0.25
Altria MO $0.54 $0.52
Morgan Stanley MS $0.05 $0.16
St. Jude Medical STJ $0.72 $0.68
Stanley Black & Decker SWK $0.97 $0.88
Textron TXT $0.13 $0.09
US Bancorp USB $0.45* $0.43
United Technologies UTX $1.30 $1.28
Wells Fargo WFC $0.60 $0.56

* Report includes items that make comparisons to the consensus estimate questionable

Wall Street Research Summary

Upgrades:

Mosaic (MOS) – Citi CareFusion (CFN) – Citi Pfizer (PFE) – Cowen VMware (VMW) – Cowen NII Holdings (NIHD) – Goldman Strayer Education (STRA) – Morgan Stanley Juniper Networks (JNPR) – Oppenheimer Harley-Davidson (HOG) – Target increased at UBS

Downgrades:

New York Times (NYT) – Argus Research Zumiez (ZUMZ) – B. Riley & co Cree (CREE) – BofA/Merrill, Morgan Stanley, Oppenheimer Alkermes (ALKS) – BofA/Merrill Amylin Pharmaceuticals (AMLN) – BofA/Merrill, Citi, Credit Suisse, Deutsche Bank Varian Medical (VAR) – Citi Eli Lilly (LLY) – Citi Occidental Petroleum (OXY) – Credit Suisse Bank of America (BAC) – Deutsche Bank, Oppenheimer MEMC Electronic Materials (WFR) – Deutsche Bank Weatherford Intl (WFT) – FBR Capital Illinois Tool (ITW) – JPMorgan Intuitive Surgical (ISRG) – Target reduced at JPMorgan

Long positions in stocks mentioned: none

For more “top stock” portfolios and research, visit TopStockPortfolios.com

 


The opinions and forecasts expressed are those of David Moenning, founder of TopStockPortfolios.com and may not actually come to pass. Mr. Moenning’s opinions and viewpoints regarding the future of the markets should not be construed as recommendations. The analysis and information in this report and on our website is for informational purposes only. No part of the material presented in this report or on our websites is intended as an investment recommendation or investment advice. Neither the information nor any opinion expressed nor any Portfolio constitutes a solicitation to purchase or sell securities or any investment program. The opinions and forecasts expressed are those of the editors of TopStockPortfolios and may not actually come to pass. The opinions and viewpoints regarding the future of the markets should not be construed as recommendations of any specific security nor specific investment advice. Stocks should always consult an investment professional before making any investment.

Any investment decisions must in all cases be made by the reader or by his or her investment adviser. Do NOT ever purchase any security without doing sufficient research. There is no guarantee that the investment objectives outlined will actually come to pass. All opinions expressed herein are subject to change without notice. Neither the editor, employees, nor any of their affiliates shall have any liability for any loss sustained by anyone who has relied on the information provided.

The analysis provided is based on both technical and fundamental research and is provided “as is” without warranty of any kind, either expressed or implied. Although the information contained is derived from sources which are believed to be reliable, they cannot be guaranteed.

The information contained in our websites and TopStockPortfolios publications is provided by Ridge Publishing Co. Inc. (Ridge). One of the principals of Ridge, Mr. David Moenning, is also President and majority shareholder of Heritage Capital Management, Inc. (HCM) a Chicago-based money management firm. HCM is registered with the U.S. Securities and Exchange Commission as an investment adviser. HCM also serves as a sub-advisor to other investment advisory firms. Ridge is a publisher and has not registered as an investment adviser. Neither HCM nor Ridge is registered as a broker-dealer.

Employees and affiliates of HCM and Ridge may at times have positions in the securities referred to and may make purchases or sales of these securities while publications are in circulation. Editors will indicate whether they or HCM has a position in stocks or other securities mentioned in any publication. The disclosures will be accurate as of the time of publication and may change thereafter without notice.

Investments in equities carry an inherent element of risk including the potential for significant loss of principal. Past performance is not an indication of future results.